LB Pharmaceuticals Logo

LB Pharmaceuticals

🇺🇸
LBRX
US50180M1080

LB Pharmaceuticals, headquartered in the USA, specializes in the development of innovative pharmaceutical solutions. The company focuses on the research and commercialization of high-quality medications, aiming to sustainably improve patient care worldwide through medical excellence.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will LB Pharmaceuticals report its next quarterly earnings?

LB Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did LB Pharmaceuticals last report quarterly earnings?

LB Pharmaceuticals last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -1.71 USD.

How often has LB Pharmaceuticals beaten expectations?

LB Pharmaceuticals has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).

How do I add the LB Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.53
Actual:
Q2 2026
Missed
Estimate:-$0.80
Actual:-$1.71
Difference:-$0.91
Q1 2026
Beat
Estimate:-$0.76
Actual:-$0.67
Difference:+$0.09
Price reaction (1 day):+3.8 %
Price reaction (7 days):-12.4 %
Q4 2025
Missed
Estimate:-$0.45
Actual:-$0.45
Difference:-$0.00
Price reaction (1 day):-2.8 %
Price reaction (7 days):+4.7 %

Earnings statistics

Estimates vs. results

1/3
Quarters above estimates
33.3%
Beat rate
-33.7%
Avg. EPS surprise

Basis: 3 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
LB Pharmaceuticals
Ticker Symbol
LBRX
ISIN
US50180M1080
Country
🇺🇸
USA
Sector